Quotes of the Day: Fauci & Pfizer

“There’s another element to [vaccine] safety. If you vaccinate someone, and they make an antibody response, and then they get exposed and infected, does the response that you induce enhance the infection and make it worse? And the only way you’ll know that is if you do an extended study not in a normal volunteer who has no risk of infection but in people who are out there in a risk situation. This would not be the first time, if it happened, that a vaccine that looked good in initial safety actually made people worse.”

- Dr. Anthony Fauci, Director of the NIAID and Chief Medical Advisor to the President of United States, March 2020 interview with Mark Zuckerberg, Chief Executive Officer of Facebook

H/T to the Vigilant Fox, on Twitter, Dec. 13th, 2021

(Translation: The only way you know if a vaccine designed to stop an infection actually makes the infection worse is to vaccinate the general population, and if the vaccine does make the infection worse it wouldn’t be the first time a vaccine has made the population less safe than the virus itself.)

And, here’s an interesting trio of articles involving COVID-19, heart problems, and Pfizer which may only be coincidentally related:

“Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning” - Steven R Gundry, 8 Nov 2021, Circulation. 2021;144:A10712, published November 8th, 2021.

“We conclude that the mRNA vaccines dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.”

“Pfizer to Acquire Arena Pharmaceuticals”- Pfizer Press Release, Monday, December 13, 2021 – 06:45am

“Arena’s pipeline includes two development-stage cardiovascular assets, temanogrel and APD418. Temanogrel is currently in Phase 2 for the treatment of microvascular obstruction and Raynaud’s phenomenon secondary to systemic sclerosis. APD418 is currently in Phase 2 for acute heart failure.”

“Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection” - Patone, M., Mei, X.W., Handunnetthi, L. et al. Nat Med (2021). https://doi.org/10.1038/s41591-021-01630-0, published December 14th, 2021.

“We estimated an extra two (95% confidence interval (CI) 0, 3), one (95% CI 0, 2) and six (95% CI 2, 8 ) myocarditis events per 1 million people vaccinated with ChAdOx1 [AstraZeneca], BNT162b2 [Pfizer–BioNTech] and mRNA-1273 [Moderna], respectively, in the 28 days following a first dose and an extra ten (95% CI 7, 11) myocarditis events per 1 million vaccinated in the 28 days after a second dose of mRNA-1273. This compares with an extra 40 (95% CI 38, 41) myocarditis events per 1 million patients in the 28 days following a SARS-CoV-2 positive test.”

(Translation: For every million people getting a two-dose COVID-19 vaccination 9 will have a myocarditis event after the first dose and 10 will have an event after the second dose, compared to 40 unvaccinated people who will have an event after being infected with COVID-19.)

People will come down with heart problems whether they’re vaccinated against COVID-19 or not. If APD418 – currently being fast-tracked for approval – is approved by the FDA and if it can address heart issues caused by COVID-19 or the COVID-19 vaccine (that’s a big “if”, and I’m not a medical professional) then it seems Pfizer’s acquisition of Arena looks like it can’t go wrong.

Thanks for Reading!

This entry was posted in Are You Kidding me?, Health, History, Media, Medicine, Quotes, The Economy and tagged , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Why ask?